258 related articles for article (PubMed ID: 25568295)
1. Age dependence of brain β-amyloid deposition in Down syndrome: An [18F]florbetaben PET study.
Jennings D; Seibyl J; Sabbagh M; Lai F; Hopkins W; Bullich S; Gimenez M; Reininger C; Putz B; Stephens A; Catafau AM; Marek K
Neurology; 2015 Feb; 84(5):500-7. PubMed ID: 25568295
[TBL] [Abstract][Full Text] [Related]
2. Parametric imaging of dual-time window [
Heeman F; Yaqub M; Hendriks J; Bader I; Barkhof F; Gispert JD; van Berckel BNM; Lopes Alves I; Lammertsma AA
Neuroimage; 2021 Jul; 234():117953. PubMed ID: 33762215
[TBL] [Abstract][Full Text] [Related]
3. PET quantification of 18F-florbetaben binding to β-amyloid deposits in human brains.
Becker GA; Ichise M; Barthel H; Luthardt J; Patt M; Seese A; Schultze-Mosgau M; Rohde B; Gertz HJ; Reininger C; Sabri O
J Nucl Med; 2013 May; 54(5):723-31. PubMed ID: 23471310
[TBL] [Abstract][Full Text] [Related]
4. Partial-Volume Effect Correction Improves Quantitative Analysis of 18F-Florbetaben β-Amyloid PET Scans.
Rullmann M; Dukart J; Hoffmann KT; Luthardt J; Tiepolt S; Patt M; Gertz HJ; Schroeter ML; Seibyl J; Schulz-Schaeffer WJ; Sabri O; Barthel H
J Nucl Med; 2016 Feb; 57(2):198-203. PubMed ID: 26541776
[TBL] [Abstract][Full Text] [Related]
5. Impact of partial volume effect correction on cerebral β-amyloid imaging in APP-Swe mice using [(18)F]-florbetaben PET.
Brendel M; Delker A; Rötzer C; Böning G; Carlsen J; Cyran C; Mille E; Gildehaus FJ; Cumming P; Baumann K; Steiner H; Haass C; Herms J; Bartenstein P; Rominger A
Neuroimage; 2014 Jan; 84():843-53. PubMed ID: 24055703
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal assessment of cerebral β-amyloid deposition in mice overexpressing Swedish mutant β-amyloid precursor protein using 18F-florbetaben PET.
Rominger A; Brendel M; Burgold S; Keppler K; Baumann K; Xiong G; Mille E; Gildehaus FJ; Carlsen J; Schlichtiger J; Niedermoser S; Wängler B; Cumming P; Steiner H; Herms J; Haass C; Bartenstein P
J Nucl Med; 2013 Jul; 54(7):1127-34. PubMed ID: 23729696
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of early-phase [
Daerr S; Brendel M; Zach C; Mille E; Schilling D; Zacherl MJ; Bürger K; Danek A; Pogarell O; Schildan A; Patt M; Barthel H; Sabri O; Bartenstein P; Rominger A
Neuroimage Clin; 2017; 14():77-86. PubMed ID: 28138429
[TBL] [Abstract][Full Text] [Related]
8. Individualized quantification of brain β-amyloid burden: results of a proof of mechanism phase 0 florbetaben PET trial in patients with Alzheimer's disease and healthy controls.
Barthel H; Luthardt J; Becker G; Patt M; Hammerstein E; Hartwig K; Eggers B; Sattler B; Schildan A; Hesse S; Meyer PM; Wolf H; Zimmermann T; Reischl J; Rohde B; Gertz HJ; Reininger C; Sabri O
Eur J Nucl Med Mol Imaging; 2011 Sep; 38(9):1702-14. PubMed ID: 21547601
[TBL] [Abstract][Full Text] [Related]
9. Optimal Reference Region to Measure Longitudinal Amyloid-β Change with
Bullich S; Villemagne VL; Catafau AM; Jovalekic A; Koglin N; Rowe CC; De Santi S
J Nucl Med; 2017 Aug; 58(8):1300-1306. PubMed ID: 28183994
[TBL] [Abstract][Full Text] [Related]
10. Optimized classification of
Bullich S; Seibyl J; Catafau AM; Jovalekic A; Koglin N; Barthel H; Sabri O; De Santi S
Neuroimage Clin; 2017; 15():325-332. PubMed ID: 28560157
[TBL] [Abstract][Full Text] [Related]
11. Amyloid imaging with (18)F-florbetaben in Alzheimer disease and other dementias.
Villemagne VL; Ong K; Mulligan RS; Holl G; Pejoska S; Jones G; O'Keefe G; Ackerman U; Tochon-Danguy H; Chan JG; Reininger CB; Fels L; Putz B; Rohde B; Masters CL; Rowe CC
J Nucl Med; 2011 Aug; 52(8):1210-7. PubMed ID: 21764791
[TBL] [Abstract][Full Text] [Related]
12. Feasibility of in vivo
Bucerius J; Barthel H; Tiepolt S; Werner P; Sluimer JC; Wildberger JE; Patt M; Hesse S; Gertz HJ; Biessen EAL; Mottaghy FM; Sabri O
Eur J Nucl Med Mol Imaging; 2017 Jul; 44(7):1119-1128. PubMed ID: 28321471
[TBL] [Abstract][Full Text] [Related]
13. Cross-sectional comparison of small animal [18F]-florbetaben amyloid-PET between transgenic AD mouse models.
Brendel M; Jaworska A; Grießinger E; Rötzer C; Burgold S; Gildehaus FJ; Carlsen J; Cumming P; Baumann K; Haass C; Steiner H; Bartenstein P; Herms J; Rominger A
PLoS One; 2015; 10(2):e0116678. PubMed ID: 25706990
[TBL] [Abstract][Full Text] [Related]
14. Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study.
Barthel H; Gertz HJ; Dresel S; Peters O; Bartenstein P; Buerger K; Hiemeyer F; Wittemer-Rump SM; Seibyl J; Reininger C; Sabri O;
Lancet Neurol; 2011 May; 10(5):424-35. PubMed ID: 21481640
[TBL] [Abstract][Full Text] [Related]
15. Impact of Tracer Retention Levels on Visual Analysis of Cerebral [
Giovacchini G; Giovannini E; Borsò E; Lazzeri P; Duce V; Ferrando O; Foppiano F; Ciarmiello A
Curr Radiopharm; 2021; 14(1):70-77. PubMed ID: 32727344
[TBL] [Abstract][Full Text] [Related]
16. Concordance in detecting amyloid positivity between
Cho SH; Choe YS; Kim YJ; Lee B; Kim HJ; Jang H; Kim JP; Jung YH; Kim SJ; Kim BC; Farrar G; Na DL; Moon SH; Seo SW
Sci Rep; 2020 Nov; 10(1):19576. PubMed ID: 33177593
[TBL] [Abstract][Full Text] [Related]
17. Florbetaben to trace amyloid-β in the Alzheimer brain by means of PET.
Barthel H; Sabri O
J Alzheimers Dis; 2011; 26 Suppl 3():117-21. PubMed ID: 21971456
[TBL] [Abstract][Full Text] [Related]
18. Head-to-Head Comparison of 18F-Florbetaben and 18F-Flutemetamol in the Cortical and Striatal Regions.
Cho SH; Choe YS; Kim YJ; Kim HJ; Jang H; Kim Y; Kim SE; Kim SJ; Kim JP; Jung YH; Kim BC; Lockhart SN; Farrar G; Na DL; Moon SH; Seo SW
J Alzheimers Dis; 2020; 76(1):281-290. PubMed ID: 32474468
[TBL] [Abstract][Full Text] [Related]
19. Impact of Training Method on the Robustness of the Visual Assessment of 18F-Florbetaben PET Scans: Results from a Phase-3 Study.
Seibyl J; Catafau AM; Barthel H; Ishii K; Rowe CC; Leverenz JB; Ghetti B; Ironside JW; Takao M; Akatsu H; Murayama S; Bullich S; Mueller A; Koglin N; Schulz-Schaeffer WJ; Hoffmann A; Sabbagh MN; Stephens AW; Sabri O
J Nucl Med; 2016 Jun; 57(6):900-6. PubMed ID: 26823561
[TBL] [Abstract][Full Text] [Related]
20. [(18)F]Florbetaben: a review in β-amyloid PET imaging in cognitive impairment.
Syed YY; Deeks E
CNS Drugs; 2015 Jul; 29(7):605-13. PubMed ID: 26175116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
